Cryoport, Inc. (CYRX)
Last Price$6.2(4.9%)
Market Cap$303.9M
CYRX Rating
CYRX Quality rating performance
CYRX Intrinsic Value
Key Highlights:
As of Mar 18, 2025 CYRX Relative Value is $10.6, which is undervalued by 72.1%, compared to current share price of $6.2.
As of Mar 18, 2025 CYRX DCF Value is N/A, which is undervalued by N/A, compared to current share price of $6.2.
CYRX Share Price History
1W (7.2%)
1M (8.9%)
6M (24.0%)
YTD (60.1%)
1Y (58.9%)
3Y (81.7%)
5Y (57.6%)
10Y (6.5%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CYRX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$303.9M
$292.9M
$228.4M
($34.0M)
Shares Outstanding
49M
Employees
1,186
Growth (CAGR)
46.4%
30.4%
35.14%
38.2%
(54.79%)
Profitability
41.7%
(29.2%)
(51.1%)
(7.1%)
(14.9%)
29.6%
Intrinsic Value
$10.7 (72.9% undervalued)
N/A
$10.7
(100.0%)
(267.0%)
Valuation (LTM)
Return on Capital
Financial Health
($11.0M)
0.3x
(23.5x)
62.4%
Dividends
Earnings
Aug 04, 2025
BEAT by 1.2%
MISS by 21.4%
40.0%
3 Beat & 7 Miss
CYRX Stock Financials
CYRX Income Statement Metrics
Annual
Quarterly
LTM
CYRX Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($16.3M) +2,056.3% YoY
Capital Expenditure (CAPEX)
($17.3M) -60.6% YoY
Free Cash Flow (FCF)
($33.6M) -25.5% YoY
CYRX Income Statement Overview
Annual
Quarterly
LTM
Mar'16
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
CYRX Balance Sheet Overview
Annual
Quarterly
LTM
Mar'16
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$703.5M
Current assets ($341.6M, 48.6% of total)
$261.7M (37.2%)
$45.8M (6.5%)
Other current assets
$34.0M (4.8%)
Non-current assets ($361.9M, 51.4% of total)
$0.0 (0.0%)
$136.0M (19.3%)
$170.5M (24.2%)
Other non-current assets
$55.4M (7.9%)
Financial position
($11.0M)
Cash & Short-term
Investments
Total Debt
CYRX Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CYRX Earnings Surprises
Crunching data... Almost there!
CYRX Dividends
CYRX Dividend Yield
Crunching data... Almost there!
CYRX Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CYRX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$303.9M | 5.3 | $10.7 72.9% undervalued | (58.9%) | $228.4M | ($34.0M) | (2.1%) | (14.9%) | 41.7% | (16.1%) | 62.4% | |
$100.9B | 6.6 | $138.9 16.9% undervalued | (17.6%) | $91.0B | $6,213.0M | 0.0% | 6.8% | 17.9% | 12.9% | 153.2% | |
$59.1B | 6.3 | $416.3 69.4% undervalued | (0.9%) | $87.4B | $2,647.0M | (0.6%) | 3.0% | 22.5% | 5.6% | 67.4% | |
$17.5B | 7.4 | $18.8 11.5% overvalued | 2.8% | CN¥42.0B | CN¥3,370.7M | 11.4% | 8.0% | 31.2% | 19.9% | 29.9% | |
$16.3B | 6.4 | $99.1 15.5% overvalued | 1.2% | $10.6B | $682.9M | 14.0% | 6.4% | 12.7% | 38.8% | 25.6% | |
$14.9B | 6.2 | $124.4 15.5% overvalued | (22.3%) | $12.1B | $617.8M | (5.8%) | 5.1% | 13.8% | 9.7% | 36.8% | |
$12.6B | 6.1 | $52.7 51.7% overvalued | (10.6%) | $8,072.0M | $15.0M | 4.2% | 0.2% | 11.3% | 9.3% | 257.2% | |
$12.0B | 5.5 | $120.0 19.9% undervalued | 39.8% | $17.7B | $447.3M | 0.7% | 2.5% | 7.5% | 16.7% | 101.1% | |
$5,277.6M | 5.6 | $176.8 18.2% undervalued | (15.4%) | $4,819.2M | $255.6M | (9.1%) | 5.3% | 15.2% | 26.6% | 3.4% | |
$4,862.0M | 5.2 | $58.2 43.0% undervalued | (17.0%) | $11.7B | $190.0M | 19.7% | 1.6% | 13.3% | 3.4% | 170.5% | |
$2,227.8M | 5.5 | $67.2 80.1% undervalued | (7.8%) | $3,946.4M | $143.6M | (6.1%) | 3.6% | 26.7% | 4.8% | 30.1% |
FAQ
What is Cryoport, Inc. (CYRX) stock rating?
As of today, Cryoport, Inc. has a stock rating of 5 (out of 10), which is considered Good.
is Cryoport, Inc. (CYRX) a good stock to buy?
As of today, Cryoport, Inc. has a Good stock rating, which is 72.9% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.